CSL shares: 3 things you need to know ahead of the 2019 AGM

As CSL’s Annual General Meeting looms, the potential of a guidance upgrade gains increased visibility from one of Australia’s top brokers.

When will CSL hold their 2019 AGM?

The CSL Annual General Meeting (AGM) is set to be held next Wednesday, on October 16.

The meeting will be held at The Westin Sydney and will commence at 13:00 AEST.

Key topics of the AGM

As with most General Meetings, during CSL’s 2019 AGM a number of key Board members will seek to be re-elected.

Specifically, CSL’s Board has endorsed the re-election of both Ms Marie McDonald and Dr Megan Clark AC.

Beyond re-elections, Dr Tadataka who served on CSL’s Board and was a member of the Innovation and Development Committee, is set to retire following the AGM.

Besides this, the company noted that it is currently searching for, ‘a Non-executive Director with experience in the bio pharmaceutical industry and R&D/ Product Development.’

Secondly, shareholders will have a chance to vote on CSL’s Remuneration Report, as well as the company’s ‘Grant of Performance Share Units to Executive Directors’.

A number of high profile companies – including NAB, Westpac, Telstra and Harvey Norman – all received first strikes against their Renumeration Reports in 2018. For reference, if a company receives two strikes – that is, if two consecutive Renumeration Reports receive more than 25% of votes against the report, a company is required to vote on a board spill.

CSL, for reference, has seen no such ‘revolt’ from shareholders in recent times. Coincidentally, the CSL share price has also risen in excess of 200% in the last five years and more than 600% in the last decade.

CSL share price: why the AGM matters?

Morgan Stanley – as we covered previously – has a current price target of A$251 per share and an ‘overweight’ rating on the biotech giant CSL.

A central part of this bullish thesis revolves around CSL potentially upgrading its already impressive FY20 guidance of NPAT growth of between 7 to 10%.

Importantly, though the investment bank believes it is probably too early to see a guidance upgrade during the AGM, Morgan Stanley does point out that it is common for guidance to be re-affirmed, upgraded, or downgraded during Annual General Meetings.

On this front, Morgan Stanley sees an AGM guidance upgrade as only 30% likely (with the projected share price hitting A$260) if such an event were to occur. Most likely however, with a 60% probability thinks the investment bank, is for CSL to simply reaffirm its current FY20 guidance during the AGM.

Year-to-date, the CSL’s stock has run-up 29%.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.